Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity.
about
Reviewing and reconsidering invasion assays in head and neck cancerDynamic myosin activation promotes collective morphology and migration by locally balancing oppositional forces from surrounding tissue.Polarized E-cadherin endocytosis directs actomyosin remodeling during embryonic wound repair.Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinomaCollective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6.Three-dimensional reconstruction of oral tongue squamous cell carcinoma at invasion front.Notch1-Dll4 signalling and mechanical force regulate leader cell formation during collective cell migration.Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis.Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch.Prognostic significance of interleukin-8 and CD163-positive cell-infiltration in tumor tissues in patients with oral squamous cell carcinoma.Epidermal growth factor receptor gene copy number aberration at the primary tumour is significantly associated with extracapsular spread in oral cancer.Concomitant loss of p120-catenin and β-catenin membrane expression and oral carcinoma progression with E-cadherin reduction.ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.Diagnostic value of cyclin-dependent kinase/cyclin-dependent kinase inhibitor expression ratios as biomarkers of locoregional and hematogenous dissemination risks in oral squamous cell carcinoma.Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition.CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinomaVascularity as assessed by Doppler intraoral ultrasound around the invasion front of tongue cancer is a predictor of pathological grade of malignancy and cervical lymph node metastasisCarbonyl Reductase 3 (CBR3) Mediates 9-cis-Retinoic Acid-Induced Cytostatis and is a Potential Prognostic Marker for Oral Malignancy.Use of NRP1, a novel biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in squamous cell carcinoma of the tongue.Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironmentCollective invasion of cancer: Perspectives from pathology and development.Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.Probing 3D Collective Cancer Invasion Using Double-Stranded Locked Nucleic Acid Biosensors.FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma.Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype.Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line.Intraoperative frozen section histological analysis of resection samples is useful for the control of primary lesions in patients with oral squamous cell carcinomaN-cadherin as a key regulator of collective cell migration in a 3D environment.Collective invasion of carcinoma cells: when the fibroblasts take the lead.pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma.Reproducibility, repeatability, and level of difficulty of two methods for tumor budding evaluation in oral squamous cell carcinoma.Prognostic impact of preoperative serum interleukin-6 levels in patients with early-stage oral squamous cell carcinoma, defined by sentinel node biopsy.MicroRNA-196a-5p is a potential prognostic marker of delayed lymph node metastasis in early-stage tongue squamous cell carcinoma.Gene expression analyses associated with malignant phenotypes of metastatic sub-clones derived from a mouse oral squamous cell carcinoma Sq-1979 cell line.Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma.
P2860
Q24289407-52B40D71-E19A-4800-91DC-B6AA559E348AQ27304907-D50B10C1-C065-4D2D-9FD1-DB6DAA54FFA7Q27310174-469290D8-7863-4269-9EB9-3DE64844D0B0Q27339711-5C8CBE52-92A9-451B-968A-13BEA13AFA52Q30497855-11482EAE-5B7F-4A69-A74B-A80AA3B453CEQ30556996-01BC86FB-4B15-46F1-B67F-82365E9BF103Q30634120-9B39982A-06FB-4323-B267-57DD7A0951D1Q34284620-5EC8FDF0-5FC0-4528-A2F5-84DD72011603Q34460713-812AB86E-7E0A-4E49-92BA-F3547B525127Q34610964-40152704-3C6B-43F7-BD4C-77C464382C8EQ34621876-7DC897C9-DDEC-4C13-B430-B1BAB8B5EF1AQ34924624-1FC881A0-9CDD-410F-B340-15F5A7A73080Q34978660-A6E812E9-6E2E-4EAC-AA56-4D1A6C0728E5Q35947929-815C998B-0F77-4677-B60A-5CB943F2EE23Q36503161-8AD7B97B-64DE-42AA-8FAB-C55605EF0D76Q36525387-20FEBF94-049D-4B87-A739-F65CB88B80F7Q36839073-ACBC64B0-5388-48BD-9F05-77A194E94710Q36968288-028EEA15-267D-4A3C-9532-9675E36D73FDQ37321171-8BD806F1-8D94-4975-B99B-6DB52E7E959EQ37530747-668B164A-263C-40EF-B326-D5A19419BC09Q38741945-C4D950EF-A66C-4948-A2D5-2312A34F5BFFQ38779225-621D4D2A-0E0E-485F-BC24-3C2CA2B40EBFQ38830884-5770C8FE-2C5A-4427-80BE-2ADA3CBB4B2FQ38921725-D89AC41A-F8B0-4A39-BC2B-06F5B10AE4C8Q39001479-C5E6EB1A-D2C3-4DB6-AAC2-058DA1A76097Q39047902-1DD3F4C5-389C-4B66-9268-6F14E7A3E2DBQ39537494-1897F464-6ADD-44AA-9311-B4FD6BF06BA8Q39544703-9132E6BF-781D-4D3D-8A70-BF13A9CA0978Q39558101-CAB3F177-DB56-4F2C-95E0-14BBE62847D8Q39589394-BB790268-3D14-4FCC-8D74-24E661F61DA9Q41865643-3CE6D155-4DF7-4282-A147-90D5B7B337FDQ42093757-B5AADB12-9770-4146-BD1D-189EA825F946Q42108626-02B1BF29-EFB7-4C22-8DB0-3FBF10B9120BQ43952951-E892760A-4DEC-4BF1-9F1C-D7F77327B834Q48312173-646A7FE8-3D57-4D3E-A1AA-AAA20F539027Q49382508-D39D3053-9D08-4B6D-A80B-797A8D5CC1B0Q49690867-02F3873D-2CC9-4071-BBF9-F2625541A2A4Q50039622-4BA443A9-FF52-40C4-BEB8-A7D34AC3EFF4Q52577953-5E7DAAF2-547C-465E-B4FF-1C0BED166616Q53064658-B3232EC2-97C9-4893-B3BA-26E769299A49
P2860
Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity.
description
1983 nî lūn-bûn
@nan
1983 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@ast
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@en
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@nl
type
label
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@ast
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@en
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@nl
prefLabel
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@ast
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@en
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@nl
P2093
P1433
P1476
Mode of invasion, bleomycin se ...... carcinoma of the oral cavity.
@en
P2093
P304
P356
10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M
P407
P577
1983-06-01T00:00:00Z